While LifeStance Health Group Inc has overperformed by 1.01%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LFST fell by -15.70%, with highs and lows ranging from $9.59 to $4.74, whereas the simple moving average jumped by 1.85% in the last 200 days.
On January 03, 2024, Barclays started tracking LifeStance Health Group Inc (NASDAQ: LFST) recommending Underweight. A report published by TD Cowen on May 15, 2023, Downgraded its rating to ‘Market Perform’ for LFST. Morgan Stanley also Upgraded LFST shares as ‘Overweight’, setting a target price of $8 on the company’s shares in a report dated January 06, 2023. Jefferies Initiated an Buy rating on November 07, 2022, and assigned a price target of $7.25. UBS March 17, 2022d its ‘Buy’ rating to ‘Neutral’ for LFST, as published in its report on March 17, 2022. JP Morgan’s report from November 09, 2021 suggests a price prediction of $12 for LFST shares, giving the stock a ‘Neutral’ rating. Cowen also rated the stock as ‘Outperform’.
Analysis of LifeStance Health Group Inc (LFST)
Further, the quarter-over-quarter increase in sales is 22.34%, showing a positive trend in the upcoming months.
To gain a thorough understanding of LifeStance Health Group Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -12.64% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.11, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and LFST is recording an average volume of 1.22M. On a monthly basis, the volatility of the stock is set at 3.88%, whereas on a weekly basis, it is put at 4.41%, with a gain of 12.94% over the past seven days. Furthermore, long-term investors anticipate a median target price of $8.79, showing growth from the present price of $6.98, which can serve as yet another indication of whether LFST is worth investing in or should be passed over.
How Do You Analyze LifeStance Health Group Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 77.42%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 23.54% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
LFST shares are owned by institutional investors to the tune of 23.54% at present.
